Losartan: il valore clinico ed economico
Losartan is an angiotensin II receptor antagonist (ARB) that has been proven effective and well tolerated in the treatment of hypertension and in the reduction of global cardiovascular risk, but is more expensive than many alternatives. The present paper resumes its main pharmacological and clinical...
Main Authors: | Lorenzo Pradelli, Mario Eandi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2004-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/783 |
Similar Items
-
Profilo clinico ed economico di oxatomide
by: Lorenzo Pradelli, et al.
Published: (2003-12-01) -
Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico
by: Lorenzo Pradelli, et al.
Published: (2005-12-01) -
Implicazioni cliniche ed economiche di tramadolo SR
by: Lorenzo Pradelli, et al.
Published: (2004-12-01) -
Il ruolo terapeutico delle statine nella riduzione del rischio cardiovascolare
by: Lorenzo Pradelli, et al.
Published: (2007-10-01) -
Rifaximina nel trattamento della malattia diverticolare: potenziale terapeutico ed economico
by: Orietta Zaniolo, et al.
Published: (2005-03-01)